Transactions
11
Insider / Encompass Health Corp
Darby John Patrick
EVP, Gen Counsel & Secretary at Encompass Health Corp
- Company
- Encompass Health Corp
- Ticker
- EHC
- First filing on record
- February 20, 2026
- Latest trade on record
- August 31, 2026
- SEC filings
- EDGAR ↗
Darby John Patrick, EVP, Gen Counsel & Secretary at Encompass Health Corp, has disclosed 11 transactions in EHC since February 20, 2026: 0 purchases (0 open-market buys) and 6 sales, worth about $4.2M at the reported prices. The latest was filed September 1, 2026, 1 day after the trade.
Open-market buys
0
Sales
6
Avg. disclosure lag
1.8d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Darby John Patrick made no purchases and 6 sales worth $3.4M, plus 5 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Darby John Patrick has traded 1 stock on record; the largest by dollars is EHC.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 6 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| F | Shares withheld for tax | 4 | 15,637 | $1.7M |
| A | Grant or award | 3 | 25,841 | $645K |
| M | Option exercise or conversion | 2 | 9,716 | $170K |
| S | Open-market sale | 2 | 13,764 | $1.7M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 11 | 0 | 6 · $3.4M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| EHC | Option / conversion M | August 31, 2026 | September 1, 2026 | 1d | 4,858 | — | — | derivative | Form 4 ↗ | |
| EHC | Sell S | August 31, 2026 | September 1, 2026 | 1d | 4,858 | $121 | $588K | Form 4 ↗ | ||
| EHC | Option / conversion M | August 31, 2026 | September 1, 2026 | 1d | 4,858 | $35 | $170K | Form 4 ↗ | ||
| EHC | Sell S | August 10, 2026 | August 11, 2026 | 1d | 8,906 | $126 | $1.1M | Form 4 ↗ | ||
| EHC | Other A | March 2, 2026 | March 3, 2026 | 1d | 5,967 | $108 | $645K | derivative | Form 4 ↗ | |
| EHC | Sell F | February 28, 2026 | March 3, 2026 | 3d | 416 | $108 | $45K | Form 4 ↗ | ||
| EHC | Sell F | February 23, 2026 | February 25, 2026 | 2d | 6,990 | $106 | $742K | Form 4 ↗ | ||
| EHC | Sell F | February 20, 2026 | February 23, 2026 | 3d | 328 | $107 | $35K | Form 4 ↗ | ||
| EHC | Sell F | February 19, 2026 | February 23, 2026 | 4d | 7,903 | $107 | $847K | Form 4 ↗ | ||
| EHC | Other A | February 19, 2026 | February 20, 2026 | 1d | 2,154 | — | — | Form 4 ↗ | ||
| EHC | Other A | February 18, 2026 | February 20, 2026 | 2d | 17,720 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| September 1, 2026 | Form 4 | 0000785161-26-000208 | 3 | published | EDGAR ↗ |
| August 11, 2026 | Form 4 | 0000785161-26-000190 | 1 | published | EDGAR ↗ |
| March 3, 2026 | Form 4 | 0000785161-26-000089 | 2 | published | EDGAR ↗ |
| February 25, 2026 | Form 4 | 0000785161-26-000065 | 1 | published | EDGAR ↗ |
| February 23, 2026 | Form 4 | 0000785161-26-000055 | 2 | published | EDGAR ↗ |
| February 20, 2026 | Form 4 | 0000785161-26-000045 | 2 | published | EDGAR ↗ |
Other insiders at Encompass Health Corp
- COLTHARP DOUGLAS E EVP & Chief Financial Officer 18 rows
- Tarr Mark J President & CEO 16 rows
- Christie Edward M III Director 11 rows
- Reidy Christopher R Director 11 rows
- O'Connor Kevin J. SVP & General Counsel 10 rows
- Tuer Patrick William EVP, Chief Operating Officer 9 rows
- Fay Edmund Sr. Vice Pres. and Treasurer 8 rows
- Price Andrew L Chief Accounting Officer 7 rows
- SCHLICHTING NANCY M Director 7 rows
- CARMICHAEL GREG D Director 6 rows
Everyone on file, with contracts and lobbying under the company's name: Encompass Health Corp.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 6 | 11 | February 20, 2026 | September 1, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.